FDA warns Shineluck Foods that its mung bean sprouts were held under insanitary conditions with pathogen testing and monitoring failures.
What happened
FDA inspected Shineluck Foods in Chicago, IL, from October 7 to October 14, 2025, and issued a Form FDA 483, a list of inspection observations; FDA says it received no response. FDA found repeated violations of the Produce Safety regulation, rules for growing, harvesting, packing, and holding produce, including gaps in environmental Listeria monitoring, incomplete testing of spent sprout irrigation water for E. coli O157:H7 and Salmonella, and an August 19, 2025 positive E. coli O157:H7 result that was not handled as required.
What FDA found
FDA says the firm did not have a written environmental monitoring plan to find Listeria monocytogenes in its sprout-growing, harvesting, packing, or holding environment.
21 CFR 112.145(a)FDA says the firm did not test spent sprout irrigation water from each production batch for E. coli O157:H7 and Salmonella.
21 CFR 112.144(b)After a positive E. coli O157:H7 result on August 19, 2025, FDA says the firm did not stop using all seeds from that lot, did not tell its seed supplier, and did not treat the seeds or show the seed lot was not the source.
21 CFR 112.142(b)(1), (b)(2), (c)(1), (c)(2)FDA observed peeling silicone strips and rough welds on a conveyor belt that carries sprouts, making cleaning and sanitizing hard.
21 CFR 112.123(a)FDA says required testing records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time.
21 CFR 112.161(b)
What FDA wants
FDA asks the firm to notify it in writing within 15 working days of the steps taken to address the violations, with an explanation and supporting documents. If corrective action cannot be completed within that time, the firm must state the reason for delay and the timeframe for completion.
Who should pay attention
- sprout growers and fresh produce processors
- retailers and foodservice buyers of mung bean sprouts
- brands sourcing sprouted products from contract growers
This is a summary. Read the original letter on fda.gov.